Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes.

The crystal structures of rhizopuspepsin complexed with two oligopeptide inhibitors have been determined. CP-69,799, an azahomostatine dipeptide isostere, had previously been associated with a displacement of the C-terminal subdomain of endothiapepsin [Sali, A., Veerapandian, B., Cooper, J. B., Foundling, S. I., Hoover, D. J., & Blundell, T. L. (1989) EMBO J. 8, 2179-2188]. Here, we report the measurement of two data sets, one from crystals soaked in the inhibitor and the other from protein crystallized in the presence of excess inhibitor. In neither case is there any significant movement of the C-terminal subdomain of the rhizopuspepsin. The data suggest that the energy associated with any conformational change is small and is overcome by the crystal packing forces. The second inhibitor, a hydrated difluorostatone, was examined in a search for transition-state analogs that could cast further light on the mechanism of action [Suguna, K., Padlan, E. A., Smith, C. W., Carlson, W. D., & Davies, D. R. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 7009-7013]. The gem-diol provides a set of contact distances with the enzyme that mimic the interactions with the tetrahedral intermediate of the substrate during catalysis. These data provide support for the suggestion that the polarization of the keto group of the peptide substrate is enhanced by a hydrogen bond from the OD1 of Asp 35 (Suguna et al., 1987).

[1]  John P. Overington,et al.  X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes , 1989, Nature.

[2]  D. Rich,et al.  Pepstatin binding to pepsin. Enzyme conformation changes monitored by nuclear magnetic resonance. , 1982, Biochemistry.

[3]  Brian W. Matthews,et al.  Structural basis of the action of thermolysin and related zinc peptidases , 1988 .

[4]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[5]  T. Blundell,et al.  X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin. , 1994, Journal of molecular biology.

[6]  M. Karplus,et al.  Dynamics of ligand binding to heme proteins. , 1979, Journal of molecular biology.

[7]  C. Abad-Zapatero,et al.  Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain , 1990, Proteins.

[8]  E. Meyer,et al.  X-ray diffraction analysis of the inhibition of porcine pancreatic elastase by a peptidyl trifluoromethylketone. , 1988, Journal of molecular biology.

[9]  D. Davies,et al.  The structure and function of the aspartic proteinases. , 1990 .

[10]  T. A. Jones,et al.  A graphics model building and refinement system for macromolecules , 1978 .

[11]  W. Watt,et al.  Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogues. , 1986, Journal of medicinal chemistry.

[12]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[13]  J Cooper,et al.  The structure of a synthetic pepsin inhibitor complexed with endothiapepsin. , 1987, European journal of biochemistry.

[14]  J. Finn,et al.  A widely useful chiral stationary phase for the high-performance liquid chromatography separation of enantiomers , 1981 .

[15]  D. Rich,et al.  Synthesis of (3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid derivatives. Analysis of diastereomeric purity , 1978 .

[16]  T L Blundell,et al.  X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution. , 1990, Journal of molecular biology.

[17]  M. James,et al.  Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin. , 1985, Biochemistry.

[18]  D. Rich,et al.  Direct carbon-13 NMR evidence for a tetrahedral intermediate in the binding of a pepstatin analog to porcine pepsin , 1982 .

[19]  Michael H. Gelb,et al.  Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. , 1994 .

[20]  L. Polgár The mechanism of action of aspartic proteases involves ‘push‐pull’ catalysis , 1987, FEBS letters.

[21]  M. Gelb,et al.  Fluoro ketone inhibitors of hydrolytic enzymes. , 1985, Biochemistry.

[22]  T. Lin,et al.  Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. , 1985, Journal of medicinal chemistry.

[23]  A. Cunningham,et al.  Effect of secondary substrate binding in penicillopepsin: contributions of subsites S3 and S2' to kcat. , 1988, Biochemistry.

[24]  J. Fried,et al.  2,2-Difluoro-3-hydroxyesters by reformatskii reaction , 1984 .

[25]  K. Fearon,et al.  Fluoro ketone containing peptides as inhibitors of human renin. , 1987, Journal of medicinal chemistry.

[26]  T L Blundell,et al.  Domain flexibility in aspartic proteinases , 1992, Proteins.

[27]  F. Salituro,et al.  Pepsin-catalysed addition of water to a ketomethylene peptide isostere: observation of the tetrahedral species by 13C-nuclear-magnetic-resonance spectroscopy. , 1985, Biochemical Society Transactions.

[28]  W A Hendrickson,et al.  Influence of solvent accessibility and intermolecular contacts on atomic mobilities in hemerythrins. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Bizzozero,et al.  Stereochemical aspects of peptide hydrolysis catalyzed by serine proteases of the chymotrypsin type , 1981 .

[30]  G. Cohen,et al.  Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis. , 1987, Journal of molecular biology.

[31]  Tom Blundell,et al.  The active site of aspartic proteinases , 1991, FEBS letters.

[32]  T. Hofmann,et al.  Rate‐determining steps in penicillopepsin‐catalysed reactions , 1990, FEBS letters.

[33]  B. Finzel Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures , 1987 .

[34]  T L Blundell,et al.  Direct observation by X‐ray analysis of the tetrahedral “intermediate” of aspartic proteinases , 1992, Protein science : a publication of the Protein Society.

[35]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[36]  M. Dewar,et al.  Mechanism of the chain extension step in the biosynthesis of fatty acids. , 1988, Biochemistry.

[37]  S. Sheriff Addition of symmetry‐related contact restraints to PROTIN and PROLSQ , 1987 .

[38]  T. L. Blundell,et al.  High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes , 1987, Nature.

[39]  A. Fedorov,et al.  Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 A resolution. , 1990, Journal of molecular biology.

[40]  R. C. Agarwal A new least‐squares refinement technique based on the fast Fourier transform algorithm: erratum , 1978 .

[41]  W. Kati,et al.  Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors. , 1985, Journal of medicinal chemistry.

[42]  T. Blundell,et al.  High‐resolution X‐ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme. , 1989, The EMBO journal.

[43]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[44]  M. James,et al.  Structure and refinement of penicillopepsin at 1.8 A resolution. , 1983, Journal of molecular biology.

[45]  J. Kraut,et al.  Subtilisin; a stereochemical mechanism involving transition-state stabilization. , 1972, Biochemistry.

[46]  M. James,et al.  Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[48]  S. Creighton,et al.  Enzymes work by solvation substitution rather than by desolvation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Deslongchamps Stereoelectronic control in the cleavage of tetrahedral intermediates in the hydrolysis of esters and amides , 1975 .

[50]  M. L. Connolly Analytical molecular surface calculation , 1983 .

[51]  V. Kostka Aspartic proteinases and their inhibitors : proceedings of the FEBS advanced course no. 84/07, Prague, Czechoslovakia, August 20-24, 1984 , 1985 .

[52]  E. Padlan,et al.  Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.